These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 12925349

  • 1. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL.
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
    [Abstract] [Full Text] [Related]

  • 2. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Aug; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M.
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P, Heikkilä P, Anttonen A, Kajanti M, Joensuu H.
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [Abstract] [Full Text] [Related]

  • 6. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [Abstract] [Full Text] [Related]

  • 7. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B, Bran G, Hörmann K, Riedel F.
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
    Detoraki A, Staiano RI, Granata F, Giannattasio G, Prevete N, de Paulis A, Ribatti D, Genovese A, Triggiani M, Marone G.
    J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
    Al-Dissi AN, Haines DM, Singh B, Kidney BA.
    Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
    [Abstract] [Full Text] [Related]

  • 10. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
    Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM.
    Cancer; 2005 Jul 15; 104(2):427-38. PubMed ID: 15952180
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ.
    Int J Oncol; 2008 Mar 15; 32(3):585-92. PubMed ID: 18292935
    [Abstract] [Full Text] [Related]

  • 13. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [Abstract] [Full Text] [Related]

  • 14. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
    Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB.
    Oral Oncol; 2007 Sep 15; 43(8):785-90. PubMed ID: 17169602
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X, Song S, Wu J, Meng L, Dong Z, Shou C.
    Biochem Biophys Res Commun; 2001 Aug 24; 286(3):505-12. PubMed ID: 11511087
    [Abstract] [Full Text] [Related]

  • 16. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C.
    Hum Pathol; 2003 Jan 24; 34(1):18-27. PubMed ID: 12605362
    [Abstract] [Full Text] [Related]

  • 17. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S, Bezdekova M, Brychta T, Tichy M.
    Neoplasma; 2008 Jan 24; 55(4):273-9. PubMed ID: 18505336
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
    Neuchrist C, Erovic BM, Handisurya A, Steiner GE, Rockwell P, Gedlicka C, Burian M.
    Laryngoscope; 2001 Oct 24; 111(10):1834-41. PubMed ID: 11801954
    [Abstract] [Full Text] [Related]

  • 19. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C.
    Clin Cancer Res; 1999 Jun 24; 5(6):1369-79. PubMed ID: 10389921
    [Abstract] [Full Text] [Related]

  • 20. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
    Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K.
    Lung Cancer; 2004 Oct 24; 46(1):11-9. PubMed ID: 15364128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.